International symposium of radiobiology of molecular radionuclide therapy

The International Symposium on the Radiobiology of Molecular Radionuclide Therapy (MRT) is a pivotal event focusing on the radiation biology of MRT, a groundbreaking anti-cancer approach.

MRT employs radiolabeled tumor-specific vectors for precise delivery of therapeutic radionuclides to cancerous lesions, inducing DNA damage and leading to cancer cell death.

Despite the global integration of established MRT treatments like [177Lu]Lu-octreotate and [177Lu]Lu-PSMA, understanding the underlying radiobiological effects is crucial for advancing current therapies and developing novel ones.

The European Working Group on the Radiobiology of MRT, through symposia such as the proposed event, aims to foster knowledge exchange, encourage investment, and facilitate networking.

The event's primary objective is to provide comprehensive updates and education on ongoing radiobiological studies related to MRT.

Scientific sessions, including invited speakers and debates, delve into various facets of MRT radiobiology, promoting a broader perspective for (young) researchers.

Beyond scientific discussions, an educational segment explores integrating models from diverse disciplines, and an interactive session on societal/outreach topics enhances engagement.

This international symposium is vital for advancing MRT radiobiology, with potential global implications for refining cancer therapies and improving health outcomes worldwide.